These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30209680)

  • 21. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
    Feng T; Ai X; An G; Yang P; Zhao Y
    ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer.
    Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z
    Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH sensitive liposomes delivering tariquidar and doxorubicin to overcome multidrug resistance of resistant ovarian cancer cells.
    Xia Y; Fang M; Dong J; Xu C; Liao Z; Ning P; Zeng Q
    Colloids Surf B Biointerfaces; 2018 Oct; 170():514-520. PubMed ID: 29960952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery.
    Liu GY; Li M; Zhu CS; Jin Q; Zhang ZC; Ji J
    Macromol Biosci; 2014 Sep; 14(9):1280-90. PubMed ID: 24866398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
    Ghaferi M; Asadollahzadeh MJ; Akbarzadeh A; Ebrahimi Shahmabadi H; Alavi SE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.
    Ju RJ; Cheng L; Xiao Y; Wang X; Li CQ; Peng XM; Li XT
    J Liposome Res; 2018 Sep; 28(3):236-248. PubMed ID: 28480778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and cytotoxicity of cisplatin-containing liposomes.
    Carvalho Júnior AD; Vieira FP; Melo VJ; Lopes MT; Silveira JN; Ramaldes GA; Garnier-Suillerot A; Pereira-Maia EC; Oliveira MC
    Braz J Med Biol Res; 2007 Aug; 40(8):1149-57. PubMed ID: 17665053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylated magnetic Prussian blue nanoparticles asa multifunctional therapeutic agent for combined targeted photothermal ablation and pH-triggered chemotherapy of tumour cells.
    Xue P; Sun L; Li Q; Zhang L; Xu Z; Li CM; Kang Y
    J Colloid Interface Sci; 2018 Jan; 509():384-394. PubMed ID: 28923735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIR Light-Activated Drug Release for Synergetic Chemo-Photothermal Therapy.
    Yuan A; Huan W; Liu X; Zhang Z; Zhang Y; Wu J; Hu Y
    Mol Pharm; 2017 Jan; 14(1):242-251. PubMed ID: 27983855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
    Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
    Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
    Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
    Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEGylated hyperbranched polyphosphoester based nanocarriers for redox-responsive delivery of doxorubicin.
    Chen C; Zheng P; Cao Z; Ma Y; Li J; Qian H; Tao W; Yang X
    Biomater Sci; 2016 Mar; 4(3):412-7. PubMed ID: 26626655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes.
    Wen L; Huang S; Du W; Zhu C; Xu H
    Drug Dev Ind Pharm; 2020 Feb; 46(2):283-295. PubMed ID: 31944130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-Based Stealth Nanoparticles for Targeted and pH-Triggered Delivery.
    Ranalli A; Santi M; Capriotti L; Voliani V; Porciani D; Beltram F; Signore G
    Bioconjug Chem; 2017 Feb; 28(2):627-635. PubMed ID: 28107619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.